[Endometriosis. Classification, etiology and therapy]

G Göretzlehner, G Görétzlehner, Göretzlehner G, J Lembke, Lembke J, Lembke S, S Lembke
Zentralblatt für Gynäkologie · 1986 · vol. 108(6) , pp. 329–40 · PMID:3716673 · W2426132827
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-14 ⓘ

This review surveys endometriosis etiology and classification systems while evaluating the advantages and disadvantages of hormonal therapies including progestagens, danazol, gestrinone, and GnRH agonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The authors supply a survey about the aetiology varied classification systems and the hormontherapy of endometriosis. We have described the advantages and disadvantages of the therapy with progestagens, danazol, gestrinon and Gn RH agonists.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genital Neoplasms, Female Adolescent Adolescent Adult Adult Age Factors Age Factors Child Child Combined Modality Therapy Combined Modality Therapy Endometriosis Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-12T06:17:10.165071+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:39:34.049699+00:00
License: CC0 · commercial use OK